IBDEI1QI ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29425,1,3,0)
 ;;=3^Pregnancy with inconclusive fetal viability, fetus 5
 ;;^UTILITY(U,$J,358.3,29425,1,4,0)
 ;;=4^O36.80X5
 ;;^UTILITY(U,$J,358.3,29425,2)
 ;;=^5017087
 ;;^UTILITY(U,$J,358.3,29426,0)
 ;;=Z39.0^^115^1462^2
 ;;^UTILITY(U,$J,358.3,29426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29426,1,3,0)
 ;;=3^Care and exam of mother immediately after del
 ;;^UTILITY(U,$J,358.3,29426,1,4,0)
 ;;=4^Z39.0
 ;;^UTILITY(U,$J,358.3,29426,2)
 ;;=^5062904
 ;;^UTILITY(U,$J,358.3,29427,0)
 ;;=Z39.1^^115^1462^1
 ;;^UTILITY(U,$J,358.3,29427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29427,1,3,0)
 ;;=3^Care and exam of lactating mother
 ;;^UTILITY(U,$J,358.3,29427,1,4,0)
 ;;=4^Z39.1
 ;;^UTILITY(U,$J,358.3,29427,2)
 ;;=^5062905
 ;;^UTILITY(U,$J,358.3,29428,0)
 ;;=Z39.2^^115^1462^10
 ;;^UTILITY(U,$J,358.3,29428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29428,1,3,0)
 ;;=3^Routine postpartum follow-up
 ;;^UTILITY(U,$J,358.3,29428,1,4,0)
 ;;=4^Z39.2
 ;;^UTILITY(U,$J,358.3,29428,2)
 ;;=^5062906
 ;;^UTILITY(U,$J,358.3,29429,0)
 ;;=N39.0^^115^1463^36
 ;;^UTILITY(U,$J,358.3,29429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29429,1,3,0)
 ;;=3^Urinary tract infection, site not specified
 ;;^UTILITY(U,$J,358.3,29429,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,29429,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,29430,0)
 ;;=R31.9^^115^1463^13
 ;;^UTILITY(U,$J,358.3,29430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29430,1,3,0)
 ;;=3^Hematuria, unspecified
 ;;^UTILITY(U,$J,358.3,29430,1,4,0)
 ;;=4^R31.9
 ;;^UTILITY(U,$J,358.3,29430,2)
 ;;=^5019328
 ;;^UTILITY(U,$J,358.3,29431,0)
 ;;=R31.0^^115^1463^12
 ;;^UTILITY(U,$J,358.3,29431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29431,1,3,0)
 ;;=3^Gross hematuria
 ;;^UTILITY(U,$J,358.3,29431,1,4,0)
 ;;=4^R31.0
 ;;^UTILITY(U,$J,358.3,29431,2)
 ;;=^5019325
 ;;^UTILITY(U,$J,358.3,29432,0)
 ;;=R31.2^^115^1463^17
 ;;^UTILITY(U,$J,358.3,29432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29432,1,3,0)
 ;;=3^Microscopic Hematuria NEC
 ;;^UTILITY(U,$J,358.3,29432,1,4,0)
 ;;=4^R31.2
 ;;^UTILITY(U,$J,358.3,29432,2)
 ;;=^5019327
 ;;^UTILITY(U,$J,358.3,29433,0)
 ;;=N39.3^^115^1463^28
 ;;^UTILITY(U,$J,358.3,29433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29433,1,3,0)
 ;;=3^Stress incontinence (female) (male)
 ;;^UTILITY(U,$J,358.3,29433,1,4,0)
 ;;=4^N39.3
 ;;^UTILITY(U,$J,358.3,29433,2)
 ;;=^5015679
 ;;^UTILITY(U,$J,358.3,29434,0)
 ;;=N39.41^^115^1463^33
 ;;^UTILITY(U,$J,358.3,29434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29434,1,3,0)
 ;;=3^Urge incontinence
 ;;^UTILITY(U,$J,358.3,29434,1,4,0)
 ;;=4^N39.41
 ;;^UTILITY(U,$J,358.3,29434,2)
 ;;=^5015680
 ;;^UTILITY(U,$J,358.3,29435,0)
 ;;=N39.46^^115^1463^18
 ;;^UTILITY(U,$J,358.3,29435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29435,1,3,0)
 ;;=3^Mixed incontinence
 ;;^UTILITY(U,$J,358.3,29435,1,4,0)
 ;;=4^N39.46
 ;;^UTILITY(U,$J,358.3,29435,2)
 ;;=^5015685
 ;;^UTILITY(U,$J,358.3,29436,0)
 ;;=Z90.79^^115^1463^1
 ;;^UTILITY(U,$J,358.3,29436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29436,1,3,0)
 ;;=3^Acquired Absence of Oth Genital Organ(s)
 ;;^UTILITY(U,$J,358.3,29436,1,4,0)
 ;;=4^Z90.79
 ;;^UTILITY(U,$J,358.3,29436,2)
 ;;=^5063596
 ;;^UTILITY(U,$J,358.3,29437,0)
 ;;=N91.2^^115^1463^2
 ;;^UTILITY(U,$J,358.3,29437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29437,1,3,0)
 ;;=3^Amenorrhea,Unspec
 ;;^UTILITY(U,$J,358.3,29437,1,4,0)
 ;;=4^N91.2
 ;;^UTILITY(U,$J,358.3,29437,2)
 ;;=^5015904
 ;;^UTILITY(U,$J,358.3,29438,0)
 ;;=N30.10^^115^1463^5
 ;;^UTILITY(U,$J,358.3,29438,1,0)
 ;;=^358.31IA^4^2
